Silencing of Bmi1 greatly decreased tumor growth of primary tumor xenografts, considerably inhibited the tumorigenic activity of secondary and tertiary tumorspheres and significantly reduced the number of cancer stem cells at the level of xenograft tumor tissue [158]. The gene discussed is BMI1; the disease is cancer.